These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 8096177

  • 1. Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships.
    Peles E, Ben-Levy R, Tzahar E, Liu N, Wen D, Yarden Y.
    EMBO J; 1993 Mar; 12(3):961-71. PubMed ID: 8096177
    [Abstract] [Full Text] [Related]

  • 2. An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4.
    Chen X, Levkowitz G, Tzahar E, Karunagaran D, Lavi S, Ben-Baruch N, Leitner O, Ratzkin BJ, Bacus SS, Yarden Y.
    J Biol Chem; 1996 Mar 29; 271(13):7620-9. PubMed ID: 8631797
    [Abstract] [Full Text] [Related]

  • 3. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
    Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I, Peles E, Ben-Baruch N, Farbstein H, Lupu R.
    Cancer Res; 1993 Nov 01; 53(21):5251-61. PubMed ID: 8106145
    [Abstract] [Full Text] [Related]

  • 4. Neu and its ligands: from an oncogene to neural factors.
    Peles E, Yarden Y.
    Bioessays; 1993 Dec 01; 15(12):815-24. PubMed ID: 7908191
    [Abstract] [Full Text] [Related]

  • 5. ErbB kinases and NDF signaling in human prostate cancer cells.
    Grasso AW, Wen D, Miller CM, Rhim JS, Pretlow TG, Kung HJ.
    Oncogene; 1997 Nov 27; 15(22):2705-16. PubMed ID: 9400997
    [Abstract] [Full Text] [Related]

  • 6. Heregulin activation of extracellular acidification in mammary carcinoma cells is associated with expression of HER2 and HER3.
    Chan SD, Antoniucci DM, Fok KS, Alajoki ML, Harkins RN, Thompson SA, Wada HG.
    J Biol Chem; 1995 Sep 22; 270(38):22608-13. PubMed ID: 7673253
    [Abstract] [Full Text] [Related]

  • 7. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms.
    Tzahar E, Levkowitz G, Karunagaran D, Yi L, Peles E, Lavi S, Chang D, Liu N, Yayon A, Wen D.
    J Biol Chem; 1994 Oct 07; 269(40):25226-33. PubMed ID: 7929212
    [Abstract] [Full Text] [Related]

  • 8. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.
    Marte BM, Jeschke M, Graus-Porta D, Taverna D, Hofer P, Groner B, Yarden Y, Hynes NE.
    Mol Endocrinol; 1995 Jan 07; 9(1):14-23. PubMed ID: 7760847
    [Abstract] [Full Text] [Related]

  • 9. Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells.
    Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, Yarden Y.
    Cell; 1992 Apr 03; 69(1):205-16. PubMed ID: 1348215
    [Abstract] [Full Text] [Related]

  • 10. Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells.
    Bacus SS, Yarden Y, Oren M, Chin DM, Lyass L, Zelnick CR, Kazarov A, Toyofuku W, Gray-Bablin J, Beerli RR, Hynes NE, Nikiforov M, Haffner R, Gudkov A, Keyomarsi K.
    Oncogene; 1996 Jun 20; 12(12):2535-47. PubMed ID: 8700512
    [Abstract] [Full Text] [Related]

  • 11. Heregulin-stimulated signaling in rat pheochromocytoma cells. Evidence for ErbB3 interactions with Neu/ErbB2 and p85.
    Gamett DC, Greene T, Wagreich AR, Kim HH, Koland JG, Cerione RA.
    J Biol Chem; 1995 Aug 11; 270(32):19022-7. PubMed ID: 7642563
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT, Leder P.
    Oncogene; 1998 Feb 12; 16(6):737-46. PubMed ID: 9488037
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.
    Beerli RR, Graus-Porta D, Woods-Cook K, Chen X, Yarden Y, Hynes NE.
    Mol Cell Biol; 1995 Dec 12; 15(12):6496-505. PubMed ID: 8524214
    [Abstract] [Full Text] [Related]

  • 17. NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways.
    Daly JM, Olayioye MA, Wong AM, Neve R, Lane HA, Maurer FG, Hynes NE.
    Oncogene; 1999 Jun 10; 18(23):3440-51. PubMed ID: 10376522
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.